Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Retracted Dilapan-s in a multiparous woman at term on induction of labour

Breadcrumb

  • Home
  • Retracted Dilapan-s In a Multiparous Woman At Term On Induction of Labour
  • Retracted Dilapan-s in a multiparous woman at term on induction of labour

Olusegun Agunbiade, Olufemi Abidoye, Emma Clark (RM) and Ali Nakash *

Department of Obstetrics and Gynaecology, Watford General Hospital, Vicarage Road, Watford, United Kingdom.
 
case study
GSC Biological and Pharmaceutical Sciences, 2024, 26(03), 110–112.
Article DOI: 10.30574/gscbps.2024.26.3.0091
DOI url: https://doi.org/10.30574/gscbps.2024.26.3.0091
Received on 29 January 2024; revised on 10 March 2024; accepted on 13 March 2024
 
The use of Dilapan-S as an agent of induction of labour has recently gained a lot of attention for its efficiency, safety profile and lack of foetal complications. However, one of its known complications is the retraction of the rods into the uterus. Fortunately, the incidence is very rare, but the mechanisms remain elusive and poorly understood. This paper is about a multiparous woman at 39 weeks with unfavourable cervix and a multiparous os who was admitted for IOL using Dilapan-S. During the digital insertion of the 5th rod, she spontaneously ruptured her membranes with retraction of four of the rods into the uterus.  Soon after, she developed uterine contractions and was transferred into the delivery suite with an improved Bishop score and a cervical dilatation of 3 cm. An augmentation of labour was commenced with oxytocin but was later discontinued due to a suspicious CTG trace. She had an emergency caesarean section for maternal request with the delivery of a healthy baby and retrieval of the four Dilapan-S rods intra-operative.
 
Dilapan-S; Retraction; Induction; Labour
 
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2024-…

Preview Article PDF

Olusegun Agunbiade, Olufemi Abidoye, Emma Clark (RM) and Ali Nakash. Retracted Dilapan-s in a multiparous woman at term on induction of labour. GSC Biological and Pharmaceutical Sciences, 2024, 26(3), 110-112. Article DOI: https://doi.org/10.30574/gscbps.2024.26.3.0091


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution